Clinical Laserthermia Systems AB (publ) publishes the outcome of the rights issue of units
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, JAPAN, OR CANADA OR ANY OTHER JURISDICTION WHERE DISTRIBUTION OF THIS PRESS RELEASE WOULD BE UNLAWFUL OR REQUIRE REGISTRATION OR ANY OTHER MEASURES BEYOND WHAT IS REQUIRED UNDER SWEDISH LAW. Lund, Sweden – The subscription period in Clinical Laserthermia Systems AB’s (publ) (“CLS” or the “Company”) rights issue of units, in which the public also was given the opportunity to participate, ended on 6 September 2022. The rights issue was subscribed to a total of 80